Struggling with alcohol cravings? Naltrexone targets the brain's reward center to minimize drinking urges and reduce harmful ...
Clinical Study Evaluating a Long-Acting Naltrexone Implant Under the FDA's 505(b)(2) Pathway ANAHEIM, CA - January 14, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer ...
If you'd like to limit alcohol consumption in line with new dietary guidelines, a 40-year-old pill is suddenly getting a ...
For a long time, she drank every day, starting at 5 p.m. Eventually, she began drinking at 3 p.m. "There were days near the end where I would decide, 'Today, I'm taking the day off,' and I would drink ...
Naltrexone, an opioid antagonist approved in 1994 by the US Food and Drug Administration for alcohol-dependence treatment, can reduce relapse rates among AD patients. Research on naltrexone's ...
The opioid antagonist naltrexone may curb impulse control disorders (ICDs) in patients with Parkinson's disease (PD), preliminary research suggests. Results from a pilot study conducted by ...
Drugs that could help millions of people who struggle with alcohol abuse problems are often overlooked by doctors and patients, according to public health officials. The medications naltrexone and ...
Alcohol-use disorders (AUDs), referring to both alcohol abuse and alcohol dependence, affect nearly 8.5 percent of the American population, are associated with numerous medical, psychiatric, family, ...
Key market opportunities for Naltrexone include expanding its applications, addressing regional supply-demand dynamics, leveraging patent-backed manufacturing advancements, and catering to diverse end ...
Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut back on drinking before it becomes a bigger health problem. Test tubes are ...
Please provide your email address to receive an email when new articles are posted on . An outpatient detoxication regimen using naltrexone was more effective for transitioning adults with opioid ...
SALT LAKE CITY, UT — Low-dose naltrexone (LDN) holds promise for treating chronic pain associated with a wide range of conditions, including fibromyalgia and myalgic encephalomyelitis/chronic fatigue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results